The company is currently developing the MedPark project, the largest medical hub in Romania, and, if everything goes according to its strategic plan, the company will replicate this model in the coming years, in the cities of Brasov, Sibiu, Cluj, Arad, according to Mihai Marcu, CEO and President of MedLife Group.

The Group’s operating profit soared 233% on the year to RON103 million in January-June 2021. Its net profit grew to RON71.5 million in the first six months of 2021, from RON10 million in the same period in 2020.

MedLife seeks to contract a new syndicated loan, in the amount of EUR50 million, in order to consolidate its position on the market. The funds will be used to accelerate the acquisitions program. MedLife also said in its report that it would announce at least two major transactions until the end of 2021 “which will enable the company to consolidate its position of absolute leader in Romania.”

MedLife Group has 22 hyperclinics in the cities of Bucharest, Timisoara, Brasov, Arad, Iasi, Galati, Craiova, Braila, Sibiu, Cluj and Constanta, a hyperclinic recently inaugurated in Oradea, 56 clinics, ten hospitals – located in Bucharest, Arad, Sibiu and Brasov, 36 laboratories, ten pharmacies and 12 dental clinics. The Group has more than 130 partners represented through private clinics in Romania.

MedLife Group has 55 subsidiaries following the acquisition of clinics and hospitals over the last years.

Medlife SA has a stock market capitalization of RON2.1 billion and its main shareholders are Mihai Marcu (15.7%), Mihaela Cristescu (14%), Nicolae Marcu (10%) and private pension fund NN, with a 12% stake.